Bio

Martin Bruehs is a partner in the Intellectual Property Group in the firm's Washington D.C. office. He serves as Head of the Firm's Chemical Patent Practice on the East Coast. Martin's practice focuses on US and international patent matters involving a range of technologies, including chemistry, pharmaceuticals, biotechnology, medical/cosmetic products and nanotechnology. He is frequently engaged by clients around the world to develop and implement patent procurement and enforcement strategies to support clients' global business initiatives across multiple different countries and regions. His practice also includes patent litigation, client counseling, patentability, validity and infringement opinions, inter partes and post-grant review, patent reissue and reexamination matters, patent interferences and intellectual property licensing. In these areas, Martin frequently works with qualified patent prosecution and litigation counsel in many different countries within and outside of Sheppard Mullin's global platform to efficiently coordinate management of client matters. In litigation matters, Martin has served as counsel in evidentiary hearings, Markman hearings, bench trials and jury trials in various federal district courts and before the US Court of Appeals for the Federal Circuit. He has also served as designated counsel in multiple declared patent interference proceedings and inter partes reviews (IPRs) , which have proceeded to final hearing proceedings, before the US Board of Patent Appeals and Interferences (BPAI) and Patent Trial and Appeal Board (PTAB), respectively.